Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
108studies shown
Showing 1-25 of 108
RecruitingNCT06929273

A Study to Assess the Long-term Safety of KarXT for the Treatment of manic episodes in Bipolarity type I (BALSAM-3)

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Australia, Bulgaria, China, Croatia, Denmark, France, Hungary, India, Israel, Italy, Japan, New Zealand, Poland, Romania, Slovakia, Spain, Sweden, Ukraine, and the United States.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Bulgaria, China, Croatia, Denmark, France, Hungary, India, Israel, Italy, Japan, New Zealand, Poland, Romania, Slovakia, Spain, Sweden, Ukraine, United States
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
RecruitingNCT06951698

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of manic episodes in Bipolarity type I

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Australia, Bulgaria, Hungary, Japan, New Zealand, Poland, and the United States.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Bulgaria, Hungary, Japan, New Zealand, Poland, United States
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
TerminatedNCT05518149

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study has public registry information. It focuses on depression and currently lists study information in Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
RecruitingNCT07412756

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, the United States, South Korea, Spain, Taiwan, and the United Kingdom.

DepressionOtherFrom 18 Years to 75 Years
Countries
Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Depression
RecruitingNCT06793397

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Czech Republic, Germany, Greece, Ireland, Poland, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 85 Years
Countries
Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
Sponsor
Cybin IRL Limited
Condition
Depression
RecruitingNCT07196501

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea, Spain, Taiwan, and the United States.

DepressionOtherOver 18 Years
Countries
Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea, Spain, Taiwan, United States
Sponsor
Neurocrine Biosciences
Condition
Depression
RecruitingNCT05357040

Antidepressant Effects of Nitrous Oxide

This study is recruiting. It focuses on depression and currently lists participation information in Australia and the United States.

DepressionOtherOver 18 Years
Countries
Australia, United States
Sponsor
University of Chicago
Condition
Depression
RecruitingNCT06378450

Dose-Response Effects of Mindfulness Meditation

This study is recruiting. It focuses on depression and currently lists participation information in Australia.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
Australia
Sponsor
University of Melbourne
Condition
Depression
CompletedNCT00819208

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

This study is completed. It focuses on anxiety and currently lists study information in Australia, Canada, France, South Korea, the United Kingdom, and the United States.

AnxietyOtherOver 18 Years
Countries
Australia, Canada, France, South Korea, United Kingdom, United States
Sponsor
Canadian Cancer Trials Group
Condition
Anxiety
RecruitingNCT06938841

Maintenance rTMS for Depression (Maitr-De)

This study is recruiting. It focuses on depression and currently lists participation information in Australia and the United States.

DepressionOtherFrom 18 Years to 80 Years
Countries
Australia, United States
Sponsor
University of California, San Diego
Condition
Depression
RecruitingNCT07136584

SOS for Caregiver Wellbeing

This study is recruiting. It focuses on depression and currently lists participation information in Australia.

DepressionOther
Countries
Australia
Sponsor
Murdoch Childrens Research Institute
Condition
Depression
Not Yet RecruitingNCT07151079

TAG TEAM - Trans Adolescent Group Therapy

This study is not yet recruiting. It focuses on anxiety and currently lists study information in Australia.

AnxietyOtherFrom 12 Years to 17 Years
Countries
Australia
Sponsor
Murdoch Childrens Research Institute
Condition
Anxiety
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This study is active but not recruiting. It focuses on schizophrenia and currently lists study information in Australia, Canada, Chile, China, Denmark, Germany, Italy, Singapore, South Korea, Spain, Switzerland, the United Kingdom, and the United States.

SchizophreniaOtherFrom 12 Years to 30 Years
Countries
Australia, Canada, Chile, China, Denmark, Germany, Italy, Singapore, South Korea, Spain, Switzerland, United Kingdom, United States
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
Active Not RecruitingNCT03788811

ERG Components in Schizophrenia and Bipolarity type I

This study is active but not recruiting. It focuses on schizophrenia and currently lists study information in Australia, Canada, and the United States.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Australia, Canada, United States
Sponsor
diaMentis Inc.
Condition
Schizophrenia